Floatz logo

Immunoglobulin G1, Anti-(Human Interleukin 1.Beta.) (Human Clone Acz885 Heavy Chain V Region)

COVID-19

University Hospital, Basel, Switzerlandmonoclonal_antibodyPhase 3Dormant
B
58/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
43/ 100
Competitive Position
95/ 100

Competitive context

32 Active assets in the COVID-19 cohort.

Asset / SponsorPhaseRating
Recombinant Adenovirus Type 5 Carrying The Gene For Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Spike Glycoprotein (Cansino Biologics)
Seventh Medical Center of PLA General Hospital
Phase 3BBB
Serostim
ClinAmygate
Phase 4BB
cc-220
Nguyen Thi Trieu, MD
Phase 4BB
Tocilizumab
National Cancer Institute (NCI)
Phase 3BB
Oxygen
Jay C. Buckey Jr.
Phase 4BB

View all 50 →

Same molecule, other indications

Immunoglobulin G1, Anti-(Human Interleukin 1.Beta.) (Human Clone Acz885 Heavy Chain V Region) is also rated in:

systemic-onset juvenile idiopathic arthritisActive
BB
Indicative · Phase 3
64 / 100
View asset →
hereditary periodic fever syndromeActive
B
Indicative · Phase 3
58 / 100
View asset →
type 2 diabetes mellitusDormant
B
Indicative · Phase 3
58 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →